The new advanced therapy products pose many challenges in front of developers and manufacturers to allow for a cost effective and large scale manufacturing. The technologies that exist today were not designed for large scale manufacturing. The need to create batch to batch consistency alongside minimal risk for contamination, scale out/up drives the industry toward automation.
ATVIO’s development team's goal is to invent and develop new automated groundbreaking technologies that will be more cost-effective and easy to use.
ATVIO has strategic partnering with MEYTAR combining engineering force with ATVIO's profound cell & gene expertise.
With the help of our collaborations from multidisciplinary companies and specialists ATVIO is building up its IP portfolio and provide innovative solution for the cell and gene therapy market.